Cargando…
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs
PURPOSE OF REVIEW: Repurposing established medicines for a new therapeutic indication potentially has important global and societal impact. The high costs and slow pace of new drug development have increased interest in more cost-effective repurposed drugs, particularly in the cancer arena. The conv...
Autores principales: | Joharatnam-Hogan, Nalinie, Alexandre, Leo, Yarmolinsky, James, Lake, Blossom, Capps, Nigel, Martin, Richard M, Ring, Alistair, Cafferty, Fay, Langley, Ruth E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882549/ https://www.ncbi.nlm.nih.gov/pubmed/33582975 http://dx.doi.org/10.1007/s11912-021-01023-z |
Ejemplares similares
-
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock
por: Almaida-Pagan, Pedro F., et al.
Publicado: (2022) -
WEE1 Inhibitor: Clinical Development
por: Kong, Anthony, et al.
Publicado: (2021) -
Development of Effective Siglec-9 Antibodies Against Cancer
por: Wang, Jun Hui Shawn, et al.
Publicado: (2022) -
Naptumomab Estafenatox: Targeted Immunotherapy with a Novel Immunotoxin
por: Eisen, Tim, et al.
Publicado: (2014) -
Cabozantinib: an Active Novel Multikinase Inhibitor in Renal Cell Carcinoma
por: Tannir, Nizar M., et al.
Publicado: (2017)